Health and Fitness Health and Fitness
Tue, December 20, 2011
[ Tue, Dec 20th 2011 ] - Market Wire
Allezoe Medical Holdings (ALZM) Completes Exclusive Licensing Deal for HPV Diagnostic Technology
[ Tue, Dec 20th 2011 ] - Market Wire
Dynavax Initiates Proof of Mechanism Trial in Lupus Patients
[ Tue, Dec 20th 2011 ] - Market Wire
Improved Treatments for Brain Cancers Highlighted .. at Annual Society of Neuro-Oncology (SNO) Meeting
[ Tue, Dec 20th 2011 ] - Market Wire
Repligen Completes Acquisition of Novozymes Biopharma Sweden AB
[ Tue, Dec 20th 2011 ] - Market Wire
Prestige Brands Holdings, Inc. Signs Definitive A .. 17 Consumer OTC Healthcare Brands in North Ameri
[ Tue, Dec 20th 2011 ] - Market Wire
Oncothyreon Files Investigational New Drug Application for ONT-10
[ Tue, Dec 20th 2011 ] - Market Wire
Equity Research on Universal Health Services Inc. .. Inc. - Healthcare Hospitals Acquiring Facilities
[ Tue, Dec 20th 2011 ] - Market Wire
Pfizer Announces FDA Acceptance For Review Of New .. inib For Adult Patients With Moderately To Severe
[ Tue, Dec 20th 2011 ] - Market Wire
Covidien anuncia obtencin de la marca CE para su software de frecuencia respiratoria Nellcora"
[ Tue, Dec 20th 2011 ] - Market Wire
Molinaas Medicaid Claims Processing System Receives Full Federal Certification in Maine
[ Tue, Dec 20th 2011 ] - Market Wire
Mylan Receives WHO Approval for Innovative 'Second-Line-in-a-Box' HIV/AIDS Treatment
[ Tue, Dec 20th 2011 ] - Market Wire
Warnex to Sell Its Analytical Services Division
[ Tue, Dec 20th 2011 ] - Market Wire
Implant Sciences' Quantum Sniffer QS-B220 Receive .. for TSA Air Cargo Screening Qualification Testin
[ Tue, Dec 20th 2011 ] - Market Wire
Salix and Progenics Announce Positive Highly Stat .. of Oral Methylnaltrexone for Phase 3 Trial in Ch
[ Tue, Dec 20th 2011 ] - Market Wire
Covidien annuncia marchio CE per software Nellcora" Respiration Rate
[ Tue, Dec 20th 2011 ] - Market Wire
Agenus and NewVac Enter Into Agreement in the Area of Personalized Cancer Vaccines
[ Tue, Dec 20th 2011 ] - Market Wire
Covidien annonce le marquage CE de son logiciel N .. cora" de surveillance de la frquence respiratoire
[ Tue, Dec 20th 2011 ] - Market Wire
Covidien meldet CE-Kennzeichnung fr Nellcora" Respiration Rate Software
Mon, December 19, 2011
[ Mon, Dec 19th 2011 ] - Market Wire
TPI Attends 30th J.P. Morgan Healthcare Conference at San Francisco
[ Mon, Dec 19th 2011 ] - Market Wire
Life Technologies to Present at Upcoming Investment Conferences in January
[ Mon, Dec 19th 2011 ] - Market Wire
The Law Firm of Levi & Korsinsky, LLP Launches an .. Securities Laws Violations by Invacare Corporatio
[ Mon, Dec 19th 2011 ] - Market Wire
Bronstein, Gewirtz & Grossman, LLC Announces Investigation into Invacare Corporation
[ Mon, Dec 19th 2011 ] - Market Wire
Imaging Diagnostic Systems Assigns ID-Matrix Systems as Exclusive Distributor for China
[ Mon, Dec 19th 2011 ] - Market Wire
Southern California Investment Forum Hosts an Inv .. hering Today at the Pacific Club in Newport Beach
[ Mon, Dec 19th 2011 ] - Market Wire
BioElectronics Announces Chinese Patent
[ Mon, Dec 19th 2011 ] - Market Wire
Unigene's 2011 Year in Review - Key Elements in Place to Address Debt in 2012
[ Mon, Dec 19th 2011 ] - Market Wire
Zimmer Initiates Quarterly Dividend and Announces New Share Repurchase Program
[ Mon, Dec 19th 2011 ] - Market Wire
Kindred Healthcare Promotes Patricia M. Henry to President of RehabCare Division
[ Mon, Dec 19th 2011 ] - Market Wire
Vermillion Completes the Acquisition of Correlogic Systems' Ovarian Cancer Diagnostics Business
[ Mon, Dec 19th 2011 ] - Market Wire
Cytori Completes IDE Filing for Chronic Myocardial Ischemia ATHENA Trial of the Celution(R) System
[ Mon, Dec 19th 2011 ] - Market Wire
Valeant Pharmaceuticals Completes Acquisition of Dermik
[ Mon, Dec 19th 2011 ] - Market Wire
Ardea Biosciences Initiates Phase 3 Clinical Development Program for Lesinurad
[ Mon, Dec 19th 2011 ] - Market Wire
Galectin Therapeutics Provides Corporate Update
[ Mon, Dec 19th 2011 ] - Market Wire
Somaxon Pharmaceuticals Hires Financial Advisor to Assist in Seeking Strategic Alternatives
[ Mon, Dec 19th 2011 ] - Market Wire
Isis Initiates Phase 1 Clinical Study of ISIS-SMNRx in Patients With Spinal Muscular Atrophy
[ Mon, Dec 19th 2011 ] - Market Wire
Equity Research on St. Jude Medical Inc. and Medt .. nt Cutbacks Affecting Medical Appliances &;
[ Mon, Dec 19th 2011 ] - Market Wire
Leading U.S. Healthcare Providers Ordering Sequenom Center for Molecular Medicine's MaterniT21 LDT
[ Mon, Dec 19th 2011 ] - Market Wire
Pharmacyclics Inc. Receives Issue Notice of Significant Bruton's Tyrosine Kinase (BTK) Patent
[ Mon, Dec 19th 2011 ] - Market Wire
PDL BioPharma Provides Fourth Quarter 2011 Revenue Guidance of $72 Million
[ Mon, Dec 19th 2011 ] - Market Wire
Pacira Pharmaceuticals, Inc. Announces Results fr .. Trial Published in Diseases of the Colon & Rectum
[ Mon, Dec 19th 2011 ] - Market Wire
DDC, One of the Largest DNA Testing Companies Wor .. the Acquisition of Orchid Cellmark's Government P
[ Mon, Dec 19th 2011 ] - Market Wire
Perceptive Informatics DataLabs EDC Solution Impl .. 15 of the Top Global Biopharmaceutical Companies
Sun, December 18, 2011
[ Sun, Dec 18th 2011 ] - Market Wire
Galapagos achieves clinical Proof-of-Mechanism milestone in GSK alliance
Sat, December 17, 2011
[ Sat, Dec 17th 2011 ] - Market Wire
Bull & Lifshitz, LLP Announces Investigation of Synovis Life Technologies, Inc.
Fri, December 16, 2011
[ Fri, Dec 16th 2011 ] - Market Wire
HealthSouth to Present at the 30th Annual J.P. Morgan Healthcare Conference
[ Fri, Dec 16th 2011 ] - Market Wire
Mylan Launches Generic Version of Toprol-XL Tablets
[ Fri, Dec 16th 2011 ] - Market Wire
Herbalife statement regarding Belgian Commercial Court Ruling
[ Fri, Dec 16th 2011 ] - Market Wire
St. Jude Medical meldt eerste implantatie in Euro .. ch onderzoek naar Portico transcatheter aortaklep
[ Fri, Dec 16th 2011 ] - Market Wire
Genomsequenzierung frdert Forschung auf dem Gebie .. weit verbreiteten Volkskrankheiten in Frankreich.
[ Fri, Dec 16th 2011 ] - Market Wire
Humana Military Makes the Holidays Brighter for Children
[ Fri, Dec 16th 2011 ] - Market Wire
ARIAD Announces Underwritersa Exercise of Over-Allotment Option
[ Fri, Dec 16th 2011 ] - Market Wire
Dehaier Medical Enters European Homecare Medical Product Market
[ Fri, Dec 16th 2011 ] - Market Wire
Landmark Publication Endorses Prana's Drug Pipeli .. Strategy for Treating Neurodegenerative Diseases
[ Fri, Dec 16th 2011 ] - Market Wire
Ariad, Delta Air Lines, BioSante, Bank of America, Boston Scientific and News Corp
[ Fri, Dec 16th 2011 ] - Market Wire
Catasys Adds Another Customer in Massachusetts
[ Fri, Dec 16th 2011 ] - Market Wire
AtriCureas Synergy Ablation System Receives FDA Approval for the Treatment of Atrial Fibrillation
[ Fri, Dec 16th 2011 ] - Market Wire
Underperforming Medtronic and Allezoe Medical Look to Turn Around Fortunes in 2012
[ Fri, Dec 16th 2011 ] - Market Wire
Recent FDA Approvals for Antares Pharma and Boston Scientific Have Done Little to Boost Shares
[ Fri, Dec 16th 2011 ] - Market Wire
China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise
[ Fri, Dec 16th 2011 ] - Market Wire
Trimel to Present Anorgasmia (FSD) Phase II Clinical Trial Results
[ Fri, Dec 16th 2011 ] - Market Wire
Valeant Pharmaceuticals Proposes to Acquire ISTA Pharmaceuticals Inc. for $6.50 Per Share in Cash
[ Fri, Dec 16th 2011 ] - Market Wire
Kensey Nash to Enter Into Mediation with St. Jude Medical over Angio-Seal Contract Disputes
[ Fri, Dec 16th 2011 ] - Market Wire
Pfizer Broadens and Extends Commitment to Help Pr .. Infants and Young Children in the Worldas Poores
[ Fri, Dec 16th 2011 ] - Market Wire
Thoratec Announces Appointment of William A. Hawkins to Board of Directors
[ Fri, Dec 16th 2011 ] - Market Wire
Valeant Announces Successful Results From Phase III Onychomycosis Trials
[ Fri, Dec 16th 2011 ] - Market Wire
La secuenciacin del genoma ayuda a la investigacin de las enfermedades pblicas en Francia
[ Fri, Dec 16th 2011 ] - Market Wire
Concord Medical to Present at the 30th Annual J.P. Morgan Healthcare Conference in January 2012
[ Fri, Dec 16th 2011 ] - Market Wire
Centene Corporation Announces 2012 Financial Guidance
Thu, December 15, 2011
[ Thu, Dec 15th 2011 ] - Market Wire
Die US-Arzneimittelbehrde FDA hat einem beschleun .. KALYDECOa" (Ivacaftor) zugestimmt, das erste pote
[ Thu, Dec 15th 2011 ] - Market Wire
Pomerantz Law Firm Investigates Claims on Behalf of Investors of SonoSite, Inc.
[ Thu, Dec 15th 2011 ] - Market Wire
The Law Firm of Levi &;; Korsinsky, LLP .. of Breaches of Fiduciary Duty by the Board of Sy
[ Thu, Dec 15th 2011 ] - Market Wire
Rigrodsky & Long, P.A. Announces Investigation of .. ite, Inc.as Sale to Fujifilm Holdings Corporation
[ Thu, Dec 15th 2011 ] - Market Wire
St. Jude gibt erste Implantation der Transkathete .. ahmen einer europischen klinischen Studie bekannt
[ Thu, Dec 15th 2011 ] - Market Wire
Orexigen Therapeutics Prices Public Offering of Common Stock and Warrants to Purchase Common Stock
[ Thu, Dec 15th 2011 ] - Market Wire
Critical Stock Alerts for Eli Lilly, NVIDIA, Inte .. mana Gold, Charles Schwab, and MF Global Holdings
[ Thu, Dec 15th 2011 ] - Market Wire
Vista Partners Updates Coverage on ADVENTRX Pharmaceuticals, Inc.;; $3.50 Target Price
[ Thu, Dec 15th 2011 ] - Market Wire
TheraBiogen Announces National Cable Television Ad Campaign Launches YouTube Page
[ Thu, Dec 15th 2011 ] - Market Wire
p-Value Capital Management, LLC Comments on Results of Myrexis, Inc. Shareholder Vote
[ Thu, Dec 15th 2011 ] - Market Wire
Graymark Healthcare Closes Acquisition of Village Sleep Center in Plano, Texas
[ Thu, Dec 15th 2011 ] - Market Wire
New Management Changes Poise USANA for Further Growth
[ Thu, Dec 15th 2011 ] - Market Wire
Covidien meldt conference call en webcast
[ Thu, Dec 15th 2011 ] - Market Wire
Gruppo di ricerca per il linfoma negli adulti (GE .. LIMID per studio sul secondo tipo di linfoma pi c
[ Thu, Dec 15th 2011 ] - Market Wire
Covidien annuncia una teleconferenza e trasmissione web
[ Thu, Dec 15th 2011 ] - Market Wire
Arrowhead to Report Fiscal 2011 Fourth Quarter and Year-End Financial Results
[ Thu, Dec 15th 2011 ] - Market Wire
Covidien plant Ausgliederung des Unternehmensbereichs Pharmazeutika
[ Thu, Dec 15th 2011 ] - Market Wire
Covidien envisage une scission de sa branche Pharmacie
[ Thu, Dec 15th 2011 ] - Market Wire
Soligenix Initiates Next Generation Anthrax Vacci .. t Program Under Agreement With Harvard University
[ Thu, Dec 15th 2011 ] - Market Wire
SciClone Pharmaceuticals Announces Final Settlement of Stockholder Derivative Litigation
[ Thu, Dec 15th 2011 ] - Market Wire
Implant Sciences Sells Over $200,000 of Quantum S .. s Trace Detectors for Building Security in Mexico
[ Thu, Dec 15th 2011 ] - Market Wire
Importante grupo cooperativo de investigacin sobr .. elige REVLIMID para el estudio del segundo subtip
[ Thu, Dec 15th 2011 ] - Market Wire
Perceptive Informatics Completes Over 500 System .. Industry Continues to Adopt Seamless eClinical S
[ Thu, Dec 15th 2011 ] - Market Wire
Illumina Hires Laura Lauman as Vice President of Marketing
Wed, December 14, 2011
[ Wed, Dec 14th 2011 ] - Market Wire
Isis Adds Three New Drugs to Its Development Pipeline
[ Wed, Dec 14th 2011 ] - Market Wire
AVI BioPharma Receives NASDAQ Notice of Minimum Bid Price Non-Compliance
[ Wed, Dec 14th 2011 ] - Market Wire
Anthera Announces Completion of Safety Review by DSMB for VISTA-16
[ Wed, Dec 14th 2011 ] - Market Wire
BioSante Pharmaceuticals Announces Results from LibiGel Efficacy Trials
[ Wed, Dec 14th 2011 ] - Market Wire
Hospira to Present at the J.P. Morgan 30th Annual Healthcare Conference Jan. 10, 2012
[ Wed, Dec 14th 2011 ] - Market Wire
ViroPharma Announces Approval of Modernized Label .. Vancocin (vancomycin hydrochloride, USP) Capsules
[ Wed, Dec 14th 2011 ] - Market Wire
Positron's Attrius Receives Health Canada Approval
[ Wed, Dec 14th 2011 ] - Market Wire
AIM Honored for Innovative Program That Helps Consumers Make Better Choices About Their Care
[ Wed, Dec 14th 2011 ] - Market Wire
Vooraanstaande samenwerkingsgroep voor lymfoomond .. ) kiest REVLIMID voor onderzoek naar tweede meest
[ Wed, Dec 14th 2011 ] - Market Wire
Amica Mature Lifestyles Announces Closing of Subs .. cluding Exercise in Full of Over-Allotment Option
[ Wed, Dec 14th 2011 ] - Market Wire
Amgen Announces Final Results of Its Tender Offer
[ Wed, Dec 14th 2011 ] - Market Wire
St. Jude Medical annuncia il primo impianto nella .. clinica per la valutazione dalla valvola cardiac
[ Wed, Dec 14th 2011 ] - Market Wire
CytoSorbents Awarded US Army SBIR Trauma Grant
[ Wed, Dec 14th 2011 ] - Market Wire
Definitieve fase 2 gegevens van evaluatie REVLIMI .. et recidiverende of refractaire chronische lymfat
[ Wed, Dec 14th 2011 ] - Market Wire
Datos finales de la Fase II que evalan REVLIMID y .. eucemia linfoctica crnica recurrente o resistente
[ Wed, Dec 14th 2011 ] - Market Wire
Premiere Cooperative Group in Adult Lymphoma Rese .. for Study in Second Most Common Lymphoma Subtype
[ Wed, Dec 14th 2011 ] - Market Wire
Salix Pharmaceuticals Announces NDA Submission fo .. emer for the Treatment of HIV-Associated Diarrhea
[ Wed, Dec 14th 2011 ] - Market Wire
Meta-analysis of Five Clinical Trials including C .. T Study Published in American Journal of Obstetri
[ Wed, Dec 14th 2011 ] - Market Wire
REVLIMID evaluado en combinacin con rituximab com .. pacientes con leucemia linfoctica crnica no trata
[ Wed, Dec 14th 2011 ] - Market Wire
Presentados en ASH los datos de un estudio de Fas .. en pacientes con mieloma indolente de alto riesgo
[ Wed, Dec 14th 2011 ] - Market Wire
OncoSec Medical Engages The Investor Relations Group
[ Wed, Dec 14th 2011 ] - Market Wire
Rsultats dfinitifs de laessai de phase II valuant .. ez les patients atteints de leucmie lymphocytaire
[ Wed, Dec 14th 2011 ] - Market Wire
Threshold Pharmaceuticals Announces Promising Pha .. Trial Results in Patients With Advanced Leukemias
[ Wed, Dec 14th 2011 ] - Market Wire
REVLIMID a t valu en combinaison avec le Rituxima .. ntiel destin aux patients atteints de leucmie lym
Tue, December 13, 2011
[ Tue, Dec 13th 2011 ] - Market Wire
Bio-Path Holdingsa Initial Phase I Data in Leukem .. s That Its Neutral Lipid Delivery Technology Anti
[ Tue, Dec 13th 2011 ] - Market Wire
Direction of Market Influences - Report Highlight .. ceutical Industries Ltd (ADR) and Sanofi SA (ADR)
[ Tue, Dec 13th 2011 ] - Market Wire
GenVec President and Chief Executive Officer Announces Retirement
[ Tue, Dec 13th 2011 ] - Market Wire
China Botanic Announces Development of New Siberian Ginseng Polysaccharide Extract Powder
[ Tue, Dec 13th 2011 ] - Market Wire
Fase 2-onderzoek evalueert klinisch profijt van p .. j eerder behandelde patinten met multipel myeloom
[ Tue, Dec 13th 2011 ] - Market Wire
Endgltige Daten aus multizentrischer Phase-II-Stu .. binationstherapie von VIDAZA und REVLIMID fr MDS-
[ Tue, Dec 13th 2011 ] - Market Wire
Nektar Announces Positive Clinical Data from Seco .. NKTR-181, a Novel Opioid Analgesic Molecule to Tr
[ Tue, Dec 13th 2011 ] - Market Wire
Stem Cell Therapeutics Announces Additions to Advisory Board
[ Tue, Dec 13th 2011 ] - Market Wire
Eindgegevens van Fase II multi-center onderzoek n .. REVLIMID bij patinten met hoogrisico MDS gepresen
[ Tue, Dec 13th 2011 ] - Market Wire
BioLineRx to Develop and Commercialize Novel Peptide Drug Candidates Discovered by Compugen
[ Tue, Dec 13th 2011 ] - Market Wire
Synergy Pharmaceuticals, Inc. reicht Klage ein ge .. Inc. und dessen Chief Scientific Officer und Sen
[ Tue, Dec 13th 2011 ] - Market Wire
Prsentation laASH des rsultats dfinitifs daune tu .. I valuant la combinaison de VIDAZA et de REVLIMID
[ Tue, Dec 13th 2011 ] - Market Wire
Une tude de phase III avec traitement continu de .. ion statistiquement considrable de la survie sans
[ Tue, Dec 13th 2011 ] - Market Wire
Phase-III-Studie mit kontinuierlicher REVLIMID-Th .. ifikante Verbesserung der progressionsfreien berl
[ Tue, Dec 13th 2011 ] - Market Wire
Threshold Pharmaceuticals Announces Update to TH- .. resented at the Oppenheimer Healthcare Conference
[ Tue, Dec 13th 2011 ] - Market Wire
NTRR Targets $390 Billion Weight Loss and Diet Management Market
[ Tue, Dec 13th 2011 ] - Market Wire
FDA Psychopharmacologic Drugs Advisory Committee Recommends Approval of Alexza's ADASUVEa"
[ Tue, Dec 13th 2011 ] - Market Wire
Radient Pharmaceuticals Launches New Onko-Sure Website, Facebook and Twitter Outreach
[ Tue, Dec 13th 2011 ] - Market Wire
Une tude de dosage value REVLIMID chez des patien .. aits, atteints de leucmie lymphocytaire chronique
[ Tue, Dec 13th 2011 ] - Market Wire
Les rsultats d'une analyse comparative rvlent que .. tistiquement significative le risque de dcs, sans
[ Tue, Dec 13th 2011 ] - Market Wire
Synergy Pharmaceuticals, Inc. dpose plainte contr .. Inc. et son conseiller scientifique en chef et VP
[ Tue, Dec 13th 2011 ] - Market Wire
Synergy Pharmaceuticals, Inc. Files Suit Against .. c. and its Chief Scientific Officer and Senior VP
[ Tue, Dec 13th 2011 ] - Market Wire
Synergy Pharmaceuticals, Inc. fa causa ad Ironwoo .. suo Direttore Scientifico e Vicepresidente Senior
[ Tue, Dec 13th 2011 ] - Market Wire
Synergy Pharmaceuticals, Inc. spant geding aan te .. , Inc. en haar Chief Scientific Officer en Senior
Mon, December 12, 2011
[ Mon, Dec 12th 2011 ] - Market Wire
Abiomed 2011 Investor Day Webcast Replay Available
[ Mon, Dec 12th 2011 ] - Market Wire
First FDA-Approved Treatment for Myelofibrosis, J .. ssed in Multiple Presentations at 2011 ASH Annual
[ Mon, Dec 12th 2011 ] - Market Wire
Paladin Labs Announces the Canadian Launch of DigiFab(TM) Digoxin Immune Fab (Ovine)
[ Mon, Dec 12th 2011 ] - Market Wire
Celldex Therapeutics Presents Novel Preclinical D .. erican Society of Hematology Meeting in San Diego
[ Mon, Dec 12th 2011 ] - Market Wire
Synageva BioPharma to Present at the 30th Annual .. Morgan Healthcare Conference on January 11, 2012
[ Mon, Dec 12th 2011 ] - Market Wire
Theravance Announces Initiation of Phase 2 Study .. ARIN Compound, TD-9855, for the Treatment of ADHD
[ Mon, Dec 12th 2011 ] - Market Wire
Lilly Oncology Reveals Findings From Study of JAK2 Inhibitor for Blood Cancers at ASH Meeting
[ Mon, Dec 12th 2011 ] - Market Wire
Community Health Systems Announces Definitive Agreement to Acquire Blue Island, Illinois Hospital
[ Mon, Dec 12th 2011 ] - Market Wire
Health Canada Approves Feraheme (ferumoxytol) to .. ency Anemia in Adults with Chronic Kidney Disease
[ Mon, Dec 12th 2011 ] - Market Wire
AMAG Pharmaceuticals Announces Preliminary Data R .. acy of a Single Infusion of 1020 mg Ferumoxytol (
[ Mon, Dec 12th 2011 ] - Market Wire
Nektar Therapeutics Initiates Phase 3 BEACON Tria .. f NKTR-102 in Women with Metastatic Breast Cancer
[ Mon, Dec 12th 2011 ] - Market Wire
ProMetic Announces Achievement of Significant Targeted Milestone With a Multinational Company
[ Mon, Dec 12th 2011 ] - Market Wire
PDL BioPharma Announces Departure of Chief Financial Officer
[ Mon, Dec 12th 2011 ] - Market Wire
Geron Initiates Phase 2 Trial of GRN1005 in Brain Metastases From Breast Cancer
[ Mon, Dec 12th 2011 ] - Market Wire
Mylan Names John Thievon President of Dey Pharma
[ Mon, Dec 12th 2011 ] - Market Wire
Soligenix Announces Publication of Results of its .. al Trial of orBec in the Prevention of Acute GVHD
[ Mon, Dec 12th 2011 ] - Market Wire
MELA Sciences Announces Additions to Board of Directors
[ Mon, Dec 12th 2011 ] - Market Wire
Emergent BioSolutions to Participate in January 2012 Investor Conferences
[ Mon, Dec 12th 2011 ] - Market Wire
PDL BioPharma Corrects Its Adjusted Conversion Rates for Its Convertible Notes
[ Mon, Dec 12th 2011 ] - Market Wire
Kraig Biocraft Laboratories Receives New Custom Z .. er Configurations for Advanced Fibers Development
[ Mon, Dec 12th 2011 ] - Market Wire
Abbott and Reata Pharmaceuticals Announce Agreeme .. ze Next-Generation Antioxidant Inflammation Modul
[ Mon, Dec 12th 2011 ] - Market Wire
10-Year Study Demonstrates IRIDEX MicroPulsea" La .. ffective for Patients with Diabetic Macular Edema
[ Mon, Dec 12th 2011 ] - Market Wire
Inovio Pharmaceuticals to Present at Oppenheimer Investor Conference
Sun, December 11, 2011
[ Sun, Dec 11th 2011 ] - Market Wire
Pharming granted U.S. patent on C1 inhibitor use in ischemia reperfusion injury indications
[ Sun, Dec 11th 2011 ] - Market Wire
Onyx Pharmaceuticals Announces FDA Standard Revie .. New Drug Application for the Treatment of Relapse
Sat, December 10, 2011
[ Sat, Dec 10th 2011 ] - Market Wire
Onyx Pharmaceuticals Provides Update on Carfilzom .. 3rd American Society of Hematology Annual Meeting
[ Sat, Dec 10th 2011 ] - Market Wire
Brower Piven Encourages Investors Who Have Losses .. nvestment in Pain Therapeutics, Inc. to Inquire A
[ Sat, Dec 10th 2011 ] - Market Wire
Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;;
[ Sat, Dec 10th 2011 ] - Market Wire
Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;;
[ Sat, Dec 10th 2011 ] - Market Wire
Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;;
[ Sat, Dec 10th 2011 ] - Market Wire
Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;; u
[ Sat, Dec 10th 2011 ] - Market Wire
Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;;
[ Sat, Dec 10th 2011 ] - Market Wire
Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;;
[ Sat, Dec 10th 2011 ] - Market Wire
Abiomed Announces Expanded Heart Recovery Strategy with Multi Year Growth Initiatives
[ Sat, Dec 10th 2011 ] - Market Wire
Exact Sciences Announces Successful Completion of Public Offering of Common Stock
[ Sat, Dec 10th 2011 ] - Market Wire
Gilead maakt tweejaarsgegevens bekend van crucial .. ie van elvitegravir, een integraseremmer voor hiv
[ Sat, Dec 10th 2011 ] - Market Wire
Gilead gibt Zweijahresdaten der Phase-3-Pivotstud .. itegravir, einem Integrasehemmer bei HIV, bekannt
[ Sat, Dec 10th 2011 ] - Market Wire
Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir, un inibitore dell
[ Sat, Dec 10th 2011 ] - Market Wire
Data Shows Medtronic AdaptiveStima" with RestoreSensora" Provides Pain Relief and Convenience
[ Sat, Dec 10th 2011 ] - Market Wire
Gilead Announces Two-Year Data From Pivotal Phase .. y of Elvitegravir, an Integrase Inhibitor for HIV
Fri, December 9, 2011
[ Fri, Dec 09th 2011 ] - Market Wire
Saxena White P.A. Files a Securities Fraud Class Action Against Hospira, Inc.
[ Fri, Dec 09th 2011 ] - Market Wire
Gilead anuncia datos de dos aos del estudio funda .. egravir, un inhibidor de la integrada para el VIH
[ Fri, Dec 09th 2011 ] - Market Wire
Leading Addiction Expert Joins Catasys as Chief Medical Officer
[ Fri, Dec 09th 2011 ] - Market Wire
Kahn Swick & Foti, LLC Announces Investigation in .. Report of Possible Federal Manufacturing Suspens
[ Fri, Dec 09th 2011 ] - Market Wire
HealthSpring, Inc. Announces Record Date and Meet .. of Stockholders in Connection with the Proposed M
[ Fri, Dec 09th 2011 ] - Market Wire
Amgen to Present at the 22nd Annual Oppenheimer Healthcare Conference
[ Fri, Dec 09th 2011 ] - Market Wire
Warnex Sells Its Medical and Forensic Testing Ope .. Reaches Repayment Agreement With Its Debentureho
[ Fri, Dec 09th 2011 ] - Market Wire
Shengtai Pharmaceutical, Inc. Announces Annual Meeting Date
[ Fri, Dec 09th 2011 ] - Market Wire
Abbott Declares 352nd Consecutive Quarterly Dividend
[ Fri, Dec 09th 2011 ] - Market Wire
Thoratec Presentation at Oppenheimer Conference to Be Webcast
[ Fri, Dec 09th 2011 ] - Market Wire
HeartWare to Present at the Oppenheimer 22nd Annual Healthcare Conference
[ Fri, Dec 09th 2011 ] - Market Wire
Quest Diagnostics Care360a" Named Top e-Prescribing Platform by Black Book Rankings
[ Fri, Dec 09th 2011 ] - Market Wire
Lilly for Better Healtha" Expands Website to Incl .. Spanish Health Information and Interactive Tools
[ Fri, Dec 09th 2011 ] - Market Wire
Lilly for Better Healtha" expande su sitio web pa .. in de salud y herramientas interactivas en espaol
[ Fri, Dec 09th 2011 ] - Market Wire
AVI BioPharma Names Jayant Aphale, Ph.D., Senior Vice President of Technical Operations
[ Fri, Dec 09th 2011 ] - Market Wire
VentriPoint Announces Proposed Issuance of Shares for Debt and Credit Facility
[ Fri, Dec 09th 2011 ] - Market Wire
Rosetta Genomics Announces New York State Approval for miRview mets?
[ Fri, Dec 09th 2011 ] - Market Wire
Edwards Lifesciences Forecasts Strong Sales and Earnings Growth in 2012
[ Fri, Dec 09th 2011 ] - Market Wire
Smart-Tek Solutions, Inc. Projects Recoup and Possible Loss Exceeded by 4th Quarter's End
[ Fri, Dec 09th 2011 ] - Market Wire
Mindray Medical to Acquire a Controlling Stake in Zhejiang Greenlander Information Technology

Presentados en ASH los datos de un estudio de Fase III que evalan REVLIMID en pacientes con mieloma indolente de alto riesgo


//health-fitness.news-articles.net/content/2011/ .. ientes-con-mieloma-indolente-de-alto-riesgo.html
Published in Health and Fitness on Wednesday, December 14th 2011 at 3:22 GMT by Market Wire   Print publication without navigation


BOUDRY, Suiza--([ ])--Celgene International Srl, filial de Celgene Corporation (NASDAQ: CELG), ha anunciado que los datos actualizados que evalan el tratamiento continuo con REVLIMID (lenalidomida) en pacientes con mieloma mltiple indolente asintomtico de alto riesgo, se han presentado en la 53 Reunin Anual de la American Society of Hematology. El estudio ha demostrado que el tratamiento previo con lenalidomida y dexametasona, seguido de lenalidomida continuada, ha retraso la aparicin de la enfermedad sintomtica y se ha demostrado una ventaja de supervivencia en comparacin con la observacin.

El comunicado en el idioma original, es la versin oficial y autorizada del mismo. La traduccin es solamente un medio de ayuda ydeber sercomparada con el texto en idioma original, que es la nica versin del texto que tendr validez legal.


Publication Contributing Sources